Develops and produces in-vitro diagnostic solutions for autoimmune, allergy and immunohematology testing

AliveDx Suisse SA

Eysins (CH) · Penicuik/Edinburgh (GB) · Chicago, IL (US) · Dubai (AE)New on Amplifa

30+ yearsExperience in in-vitro diagnostics

4Locations (CH, GB, US, AE)

SALegal form (joint-stock company, Switzerland)

About AliveDx

AliveDx Suisse SA is a company specialized in in-vitro diagnostics (IVD), headquartered in Eysins, Switzerland. With more than 30 years of experience, the company develops and produces solutions for the diagnosis of autoimmune diseases, allergies and immunohematology. The product portfolio includes the automated multiplex testing platform MosaiQ, the all-in-one immunofluorescence solution LumiQ, and the manual blood bank reagents product line Alba. The production sites in Eysins (Switzerland) and Edinburgh (UK) are certified to EN ISO 13485:2016 within the framework of the IVDR. In addition to technical support and product consulting, the company offers OEM solutions for blood bank reagents as well as support for scientific and clinical studies.

Site: Eysins
Processes: Technical support and customer service (evaluations, product consulting), OEM solutions (blood bank reagents), Scientific/clinical study support (Investigator-initiated Research)
Materials: MosaiQ®, LumiQ®, Alba
Certificates: EN ISO 13485:2016 (IVDR certification of the production sites Eysins/CH and, EN ISO 13485:2016 (IVDR)
Industries: In-vitro diagnostics (IVD), Immunohematology/blood bank reagents, Autoimmune diagnostics, Allergy diagnostics, Clinical laboratory diagnostics

01
Product development (MosaiQ, LumiQ, Alba)
02
Reagent production (Eysins, Edinburgh)
03
Quality inspection according to IVDR
04
Sales & distribution
05
Technical support & customer service

Products & Solutions

MosaiQ

MosaiQ®

Automated multiplex and multi-modality testing platform for rapid in-vitro test results, including AiPlex® CTDplus with a 15-IgG autoantibody profile.

LumiQ

LumiQ®

All-in-one immunofluorescence (IFA) solution for efficient laboratory workflows from sample to result.

Alba

Manual blood bank reagents for patient and donor blood screening for safe and timely transfusion matching, also available as an OEM solution.

Locations

Eysins

Global HQ & production site (Business Park Terre Bonne, Route de Crassier 13)

Materials: IVD reagents

Penicuik (Milton Bridge)

Alba Bioscience Limited site, production site (5 James Hamilton Way)

Materials: Blood bank reagents

Chicago, IL

Alba Bioscience Inc. site (171 North Aberdeen Street, Suite 400)

Dubai

AliveDx Middle-East & Africa FZ-LLC site (Dubai Healthcare City, Building 26, Office 211)

Products

**MosaiQ® AiPlex Assays**Multiplex immunoassay · Clinical laboratory diagnostics

**Alba Elution Kit**Blood bank reagents · Immunohematology

Inside the production

Field of application: allergy diagnostics

Industries

In-vitro diagnostics (IVD)Immunohematology/blood bank reagentsAutoimmune diagnosticsAllergy diagnosticsClinical laboratory diagnostics

Additional services

Technical support and customer service (evaluations, product consulting)OEM solutions (blood bank reagents)Scientific/clinical study support (Investigator-initiated Research)

Quality & Certification

The production sites in Eysins (Switzerland) and Edinburgh (UK) are certified to EN ISO 13485:2016 within the framework of the EU IVDR, a prerequisite for the distribution of IVD products in the EU.

Evidence	Eysins	Penicuik (Milton Bridge)
EN ISO 13485:2016 (IVDR)

History

2022
Publication of the form for Investigator-initiated Research (22.04.2022)
2023
IVDR certification (EN ISO 13485:2016) obtained for the production sites Eysins (CH) and Edinburgh (UK) (November)
2026
Distribution partnership with the African Biotechnology Society (ABS) for MosaiQ and LumiQ in Tunisia (July)
2026
Named a Great Place to Work® for the second consecutive time (June)
2026
Publication of the ESG Report 2025 (September)